Effect of Shuganjianpi Therapy on Immunologic Function after Transcatheter Arterial Chemoembolization in Liver Cancer Patients

Objective To study the effect of Shuganjianpi therapy(SGJPT) on the immunologic function after transcatheter arterial chemoembolization(TACE) in liver cancer patients.Methods A total of 103 patients with mid-advanced primary hepatic carcinoma were randomly divided into two groups,i.e.trial group and control group.Western medicines were used to protect hepatic function and alleviate symptoms after TACE in all the 103 patients.Since seven days before TACE,the patients in the trial group had been taking SGJP herbal medicine,which was plus or minuswith the symptoms after TACE.TACE was used in the control group alone.T lymphocyte subgroup was measured in both the two groups before the first TACE and four weeks after the second TACE,respectively.Results Although there were no significant differences in nature killer cell,CD3,CD4 and CD4/CD8 ratio between the two groups before the first TACE,the above parameters all decreased in the control group and increased in the trial group four weeks after the second TACE,which indicated significant differences between the two groups(P0.05).Conclusion Shuganjianpi therapy can advance immunologic function of liver cancer patients after transcatheter arterial chemoembolization.